Stocks · Health care · Pharmaceutical Preparations

Zentalis Pharmaceuticals, Inc.

ZNTL Clue Score26
United States Fiscal year ends December CIK 0001725160 Results filed 6 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Vincent Vultaggio
10 Feb 2026
PAO and PFO
Sold on a plan
6,894
$2.42
$16.70K
Vincent Vultaggio
9 Feb 2026
PAO and PFO
Sold on a plan
3,379
$2.39
$8.09K
Vincent Vultaggio
6 Feb 2026
PAO and PFO
Sold on a plan
29,951
$2.43
$72.77K
Vincent Vultaggio
3 Feb 2026
PAO and PFO
Sold on a plan
556
$2.52
$1.40K
Vincent Vultaggio
2 Feb 2026
PAO and PFO
Sold on a plan
2,540
$2.55
$6.48K

What was left out

Form 4 filings counted 18
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 0
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 409,427
History held since 8 Apr 2020